Mondalis, Hamraida L.
HRN: 29-48-79 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/17/2026
CEFUROXIME 500MG (TAB)
08/17/2026
08/23/2026
PO
500mg
BID
UTI Following Delivery
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: